BioNTech SE (BNTX)

156.49
+5.51(+3.65%)
Pre Market
163.56
+7.07(+4.52%)
- Real-time Data
  • Volume:
    4,058,078
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    152.56 - 166.50

BNTX Overview

Prev. Close
150.98
Day's Range
152.56-166.5
Revenue
15.64B
Open
157.15
52 wk Range
90.29-462.56
EPS
33.42
Volume
4,058,078
Market Cap
37.8B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
3,468,880
P/E Ratio
4.68
Beta
-
1-Year Change
41.48%
Shares Outstanding
241,521,065
Next Earnings Date
04 Apr 2022
What is your sentiment on BioNTech SE?
or
Market is currently closed. Voting is open during market hours.

  • SPLK, BNTX among after-hour movers
    • BySeeking Alpha-

    Galera Therapeutics (GRTX) +15%.Splunk (SPLK) +7%.Digital World Acquisition DWAC +6%.Momentus (MNTS) +6%.Cabaletta Bio CABA +6%.Aspen ASPU -21%.Communications Systems (JCS)...

  • Dow Futures Fall 110 Pts; Jobless Claims Data Due
    • ByInvesting.com-

    By Peter Nurse   Investing.com - U.S. stocks are seen opening marginally lower Thursday, as investors take stock after three days of solid gains on lessening concerns over the...

BioNTech SE Company Profile

Employees
2800

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116 for non-small cell lung cancer.It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122), which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT153 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT221 for other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II a clinical trial to treat multiple solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody, which is in Phase I/IIa clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; prophylactic vaccine for COVID-19 and Influenza; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Genevant Sciences GmbH; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; and Regeneron Pharmaceuticals, Inc. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellSellNeutral
Technical IndicatorsStrong SellStrong SellStrong BuyStrong SellNeutral
SummaryStrong SellStrong SellNeutralStrong SellNeutral
  • Financial figures state 12$ per share per sept quarter… Dec21 quarter 8$ per share per quarter… simple math shows this stock is worth at least 300$.
    0
    • Think long, this is 270Euro value stock
      0
      • The drop in price has no logical explanation! This company is producing best vaccine that will long live with humanity. Its fair value today is 270 Euro! Investors are throwing away a good opportunity by selling!
        0
        • Price crash due to fake news of Pfizer CEO arrest? Huge buy opportunity right now.
          1
          • We are Habesha kemis traditional dresses shop
            0
            • Big buy now!
              2
              • Good news FDA had authorised extra dose vaccine!
                2
                • Not quite! Authorisation is restricted to the severely immunocompromised
                  0
              • Buy?
                0
                • 3rd fose covid vaccine
                  0
                  • latest news. FDA reported to give full approval of Pfizer covid vaccine by Labor Day.
                    0
                    • Could this stock reac $1000?
                      1
                      • Saving the world. Moreover, Still very bullish, indicators: Ichimoku, MFI, OBV, MA, etc. Good week. VIX = minimums (1 Y). Have a nice week!
                        0
                        • funny how some of these companies floated just before the crash...
                          2
                          • 200 euros tonight
                            0
                            • Any prediction for tommorow?
                              0
                              • Thanks you management services. Bullish
                                0
                                • Any idea why price of Pfizer is dropping but BioNTech is rising
                                  0
                                  • Could be sale deals in europe for vaccines but since pfizer gives high antibodies as reported in the news yesterday it should go up again this coming month.
                                    0
                                • target 130 💪🏼
                                  0
                                  • 135
                                    0
                                • vaccine is not working
                                  8
                                  • Vaccine is working as I know !?
                                    0
                                  • András Csath yeah It is working. Benny is just manipulating mate
                                    0
                                  • Your education isn't working
                                    0
                                • Any idea why the price is dropping everyday?
                                  0
                                  • Possibly because of alergic reactions to the vaccine shown by approx 10 patients. Alternatively the new variant in UK is scaring people that the vaccine will no longer work
                                    0
                                  • No idea. I am asking this question myself. And all other values going up. Guess speculation phase sith vaccine has reached its limits
                                    0
                                  • Definitely profit taken. No other better news after approval , same as Moderna.
                                    0
                                • BioNTech Says Can Make Mutation-Beating Vaccine In 6 Weeks Covid-19 Vaccine: "Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," said Ugur Sahin. https://www.ndtv.com/world-news/biontech-says-can-make-mutation-beating-coronavirus-vaccine-in-six-weeks-news-agency-afp-2342027
                                  0
                                  • Any ideas on price?
                                    0
                                    • Not Bad. It could fall somewhere between 104-106 in short term. But profitable in long run. (Not an investment advice)
                                      0
                                    • Good for long term. ❤️
                                      0
                                    • Goood for you ..
                                      0
                                  • https://www.nzherald.co.nz/world/covid-19-coronavirus-oxford-vaccine-will-be-ready-by-christmas-says-professor-leading-the-project/N5VKSFNULMSXMFITODAWLQV3SU/
                                    0
                                    • Hmmmmmm🤔Data looks strong to me. 150 soon
                                      0
                                      • Aged like milk.
                                        0
                                      • This is the Juice
                                        0
                                      • This is the Juice
                                        0
                                    • -8% speaks volumes about the apparent vaccine lol
                                      0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.